NCT00267852 - Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis | Biotech Hunter

Enrollment

152

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

Rheumatoid Arthritis

Interventions

OTHER

as clinical practice

Dosage, form, frequency and duration as per ordinary clinical practice

Trial Locations (16)

10128

Pfizer Investigational Site, Torino

16011

Pfizer Investigational Site, Arenzano

25125

Pfizer Investigational Site, Brescia

27100

Pfizer Investigational Site, Pavia

35128

Pfizer Investigational Site, Padua

44100

Pfizer Investigational Site, Ferrara

53100

Pfizer Investigational Site, Siena

56126

Pfizer Investigational Site, Pisa

60035

Pfizer Investigational Site, Iesi

70124

Pfizer Investigational Site, Bari

80131

Pfizer Investigational Site, Napoli

90100

Pfizer Investigational Site, Palermo

98122

Pfizer Investigational Site, Messina

98127

Pfizer Investigational Site, Messina

00161

Pfizer Investigational Site, Rome

Unknown

Pfizer Investigational Site, Genova

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY